Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management

NCT05062902 is registered in ClinicalTrials.gov with HillMed Inc. as lead sponsor.

NCT NCT05062902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05062902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management
Lead sponsor
HillMed Inc.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 15, 2025
Completion date
December 1, 2027
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain, interstitial cystitis, pelvic floor disorders, pelvic floor; relaxation